The time course of metabolites in human plasma after 6-[18F]fluoro-L-m-tyrosine administration

European Journal of Nuclear Medicine

Volumn 26, Issue 11, 1999, Pages 1407-1412

  Wahl, Lindi M ^a   Chen, Jia Jun ^b   Thompson, Margo ^b   Chirakal, Raman ^b   Nahmias, Claude ^b  

^a INSTITUTE FOR ADVANCED STUDY   (United States)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

6 18F fluoro L m tyrosine; Plasma metabolites; Positron emission tomography

Indexed keywords

6 FLUOROTYROSINE F 18; AROMATIC LEVO AMINO ACID DECARBOXYLASE; CARBIDOPA; FLUORINE 18; LEVODOPA; MANDELIC ACID; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; DOPAMINE METABOLISM; DRUG HALF LIFE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METABOLITE; METHYLATION; PLASMA; RADIOACTIVITY; TIME;

ANTIPARKINSON AGENTS; BRAIN; CARBIDOPA; DOPAMINE; FLUORINE RADIOISOTOPES; HUMANS; PARKINSON DISEASE; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TYROSINE;

EID: 0032724818     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050472     Document Type: Article

References (26)

1. Eidelberg D. Positron emission tomography studies in Parkinsonism. Neurol Clin 1992; 10: 421-433.
2. Snow BJ. Positron emission tomography in Parkinson's disease. Can J Neurol Sci 1992; 19: 138-141.
3. 18F]-6-fluorodopa during positron emission tomography: elimination and metabolism in carbidopa treated subjects. Life Sci 1986; 39: 2243-2252.
4. 18F]fluoro-L-3,4-dihydroxyphenylalanine in the primate. J Neurochem 1987; 48: 1077-1082.
5. 18F-fluorodopa in the hooded rat. Biochem Pharm 1988; 37: 247-250.
6. 18F]fluoro-L-dopa in rat. J Cereb Blood Flow Metab 1990; 10: 707-710.
7. 18F]6-fluoro-3-O-methyl-L-dopa in the human brain. J Cereb Blood Flow Metab 1994; 14: 664-670.
8. DeJesus O, Mukherjee J. Radiobrominated m-tyrosine analog as potential CNS L-dopa PET tracer. Biochem Biophys Res Commun 1988; 150: 1027-1031.
9. 18F-6-fluoro-L-m-tyrosine to study the dopaminergic pathway in man. J Cereb Blood Flow Metab 1993; 13: S290.
10. 18F]6-fluoro-L-m-tyrosine in the human brain. Mov Disord 1995; 10: 298-304.
11. 18F]6-fluoro-L-m-tyrosine in clinical studies of movement disorders. J Cereb Blood Flow Metab 1997; 17: S685.
12. 18F]fluoro-L-dopa for the delineation of dopaminergic structures in the human brain. J Label Comp Radiopharm 1991; 30: 266-268.
13. Barrio JR, Huang S-C, Yu D-C, Melega WP, Quintana J, Cherry SR, Jacobson A, Namavari M, Satyamurthy N, Phelps M. Radiofluorinated L-m-tyrosines: new in-vivo probes for central dopamine biochemistry. J Cereb Blood Flow Metab 1996; 16: 667-678.
14. DeJesus O, Endres CJ, Shelton SE, Nickles RJ, Holden JE. Evaluation of fluorinated m-tyrosine analogs as PET imaging agents of dopamine nerve terminals: comparison with 6-fluorodopa. J Nucl Med 1997; 38: 630-636.
15. 18F]fluoro-L-m-tyrosine. Neuroimage 1997; 5: B71.
16. Brownell GL, Kearfott KJ, Kairento AL, Elmaleh DR, Alpert NM, Correia JA, Wechsler L, Ackerman RH. Quantitation of regional cerebral glucose metabolism. J Comput Assist Tomogr 1983; 7: 919-924.
17. 18F]-L-6-fluorodopa and its metabolites in blood plasma is essential for accurate positron emission tomography studies. Life Sci 1991; 50:309-18.
18. Gjedde A, Reith J, Dyve S, Leger G, Guttman M, Diksic M, Evans A, Kuwabara H. Dopa decarboxylase activity of the living human brain. Proc Nat Acad Sci USA 1991; 88: 2721-2725.
19. Takikawa S, Dhawan V, Chaly T, Robeson W, Dahl R, Zanzi I, Mandel F, Spetsieris P, Eidelberg D. Input functions for 6-[fluorine-18]fluorodopa quantitation in parkinsonism: comparative studies and clinical correlations. J Nucl Med 1994; 35: 955-963.
20. Wahl LM, Nahmias C. Modeling of fluorine-18-6-fluoro-L-dopa in humans. J Nucl Med 1996; 37: 432-437.
21. Takikawa S, Dhawan V, Spetsieris P, Robeson W, Chaly T, Dahl R, Margouleff D, Eidelberg D. Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. Radiology 1993; 188: 131-136.
22. 18F labelled fluoro-m-tyrosine, fluoro-m-tyramine and fluoro-3-hydroxyphenylacetic acid. Appl Radiat Isot 1991; 42: 113-119.
23. 18F labelled 2- and 6-fluoro isomers of fluorodopa, fluoro-3-O-methyl-dopa and fluoro-m-tyrosine. J Label Comp Radiopharm 1995; 37: 681-683.
24. 18F]fluoro-L-dopa plasma input curves with and without carbidopa and in hemi-MPTP lesioned Monkeys. Appl Radiat Isot 1991; 42: 847-854.
25. 18F]-fluorodopamine and analogs. J Cereb Blood Flow Metab 1995; 15: S652.
26. Nutt JG, Woodward WR, Anderson JL. The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: the mechanism of action in the treatment of Parkinson's disease. Ann Neurol 1985; 18: 537-543.